All Pharma News
CytomX Q1 2024 Results, CX-904 Phase 1a Data Update On May 8

CytomX Q1 2024 Results, CX-904 Phase 1a Data Update On May 8
GLOBENEWSWIRE
01 May 2024
Share Share
CytomX Announces First Dosed with CX-2051 in a Ph 1 Study for Neoplasms

CytomX Announces First Dosed with CX-2051 in a Ph 1 Study for Neoplasms
GLOBENEWSWIRE
08 Apr 2024
Share Share
CytomX Announces Nomination of Candidate in PROBODY TCB Collab with Astellas

CytomX Announces Nomination of Candidate in PROBODY TCB Collab with Astellas
GLOBENEWSWIRE
03 Apr 2024
Share Share
CytomX Achieves $5M Astellas Milestone

CytomX Achieves $5M Astellas Milestone
CONTRACT PHARMA
03 Apr 2024
Share Share
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
GLOBENEWSWIRE
21 Mar 2024
Share Share
CytomX Announces Achievement in PROBODY® TCB Collaboration with Astellas

CytomX Announces Achievement in PROBODY® TCB Collaboration with Astellas
GLOBENEWSWIRE
18 Mar 2024
Share Share
BMS exits next-gen Yervoy pact, taking $300M in biobucks with it

BMS exits next-gen Yervoy pact, taking $300M in biobucks with it
FIERCE BIOTECH
13 Mar 2024
Share Share
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GLOBENEWSWIRE
11 Mar 2024
Share Share
CytomX to Report Fourth Quarter and Full Year 2023 Financial Results

CytomX to Report Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
04 Mar 2024
Share Share
CytomX Therapeutics to Present at Upcoming March Investor Conferences

CytomX Therapeutics to Present at Upcoming March Investor Conferences
GLOBENEWSWIRE
27 Feb 2024
Share Share